Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia

Kevin T McVary,1 Bilal Chughtai,2 Larry E Miller,3 Samir K Bhattacharyya,4 Ryan A Dornbier,1 Dean S Elterman5 1Center for Male Health, Department of Urology, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA; 2Department of Urology, Department of Obstetrics and Gynecolog...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	McVary KT, Chughtai B, Miller LE, Bhattacharyya SK, Dornbier RA, Elterman DS
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	benign prostatic hyperplasia luts minimally invasive surgical treatment mist rezum urolift Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/8df42738697f473781be364fa3f66154
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8df42738697f473781be364fa3f66154
record_format	dspace
spelling	oai:doaj.org-article:8df42738697f473781be364fa3f661542021-12-02T10:34:37ZPutting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia1179-1470https://doaj.org/article/8df42738697f473781be364fa3f661542021-02-01T00:00:00Zhttps://www.dovepress.com/putting-patients-ahead-by-leaving-nothing-behind-an-emerging-treatment-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Kevin T McVary,1 Bilal Chughtai,2 Larry E Miller,3 Samir K Bhattacharyya,4 Ryan A Dornbier,1 Dean S Elterman5 1Center for Male Health, Department of Urology, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA; 2Department of Urology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA; 3Department of Biostatistics, Miller Scientific, Johnson City, TN, USA; 4Health Economics & Market Access, Boston Scientific, Marlborough, MA, USA; 5Division of Urology, University Health Network, Toronto, ON, CanadaCorrespondence: Kevin T McVaryCenter for Male Health, Department of Urology, Stritch School of Medicine, Loyola University Medical Center, 2160 S, First Ave, Maywood, IL 60153, USAEmail kmcvary@gmail.comAbstract: Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are highly prevalent in older men. The long-term clinical utility of lifestyle modification and oral medications for LUTS is limited. There is a great clinical need for safe, effective, and durable BPH therapies for men who unsuccessfully attempt conservative measures. Enthusiasm for transurethral resection of the prostate has declined due to surgical risk, high rates of postoperative sexual dysfunction, and the perceived invasive nature therein. Consequently, interest has grown in developing minimally invasive surgical treatments (MISTs) that are efficacious but with a more favorable risk profile in order to better align with patient preferences. This review evaluates currently available MISTs for BPH. Further, we critically examine a “Leave Nothing Behind” philosophy in MIST for BPH since implantation of permanent metallic devices may be associated with increased long-term failure rates.Keywords: benign prostatic hyperplasia, LUTS, minimally invasive surgical treatment, MIST, Rezum, UroLiftMcVary KTChughtai BMiller LEBhattacharyya SKDornbier RAElterman DSDove Medical Pressarticlebenign prostatic hyperplasialutsminimally invasive surgical treatmentmistrezumuroliftMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 14, Pp 59-64 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	benign prostatic hyperplasia luts minimally invasive surgical treatment mist rezum urolift Medical technology R855-855.5
spellingShingle	benign prostatic hyperplasia luts minimally invasive surgical treatment mist rezum urolift Medical technology R855-855.5 McVary KT Chughtai B Miller LE Bhattacharyya SK Dornbier RA Elterman DS Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
description	Kevin T McVary,1 Bilal Chughtai,2 Larry E Miller,3 Samir K Bhattacharyya,4 Ryan A Dornbier,1 Dean S Elterman5 1Center for Male Health, Department of Urology, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, USA; 2Department of Urology, Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, USA; 3Department of Biostatistics, Miller Scientific, Johnson City, TN, USA; 4Health Economics & Market Access, Boston Scientific, Marlborough, MA, USA; 5Division of Urology, University Health Network, Toronto, ON, CanadaCorrespondence: Kevin T McVaryCenter for Male Health, Department of Urology, Stritch School of Medicine, Loyola University Medical Center, 2160 S, First Ave, Maywood, IL 60153, USAEmail kmcvary@gmail.comAbstract: Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are highly prevalent in older men. The long-term clinical utility of lifestyle modification and oral medications for LUTS is limited. There is a great clinical need for safe, effective, and durable BPH therapies for men who unsuccessfully attempt conservative measures. Enthusiasm for transurethral resection of the prostate has declined due to surgical risk, high rates of postoperative sexual dysfunction, and the perceived invasive nature therein. Consequently, interest has grown in developing minimally invasive surgical treatments (MISTs) that are efficacious but with a more favorable risk profile in order to better align with patient preferences. This review evaluates currently available MISTs for BPH. Further, we critically examine a “Leave Nothing Behind” philosophy in MIST for BPH since implantation of permanent metallic devices may be associated with increased long-term failure rates.Keywords: benign prostatic hyperplasia, LUTS, minimally invasive surgical treatment, MIST, Rezum, UroLift
format	article
author	McVary KT Chughtai B Miller LE Bhattacharyya SK Dornbier RA Elterman DS
author_facet	McVary KT Chughtai B Miller LE Bhattacharyya SK Dornbier RA Elterman DS
author_sort	McVary KT
title	Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
title_short	Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
title_full	Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
title_fullStr	Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
title_full_unstemmed	Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
title_sort	putting patients ahead by leaving nothing behind: an emerging treatment paradigm in minimally invasive surgical therapy for benign prostatic hyperplasia
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/8df42738697f473781be364fa3f66154
work_keys_str_mv	AT mcvarykt puttingpatientsaheadbyleavingnothingbehindanemergingtreatmentparadigminminimallyinvasivesurgicaltherapyforbenignprostatichyperplasia AT chughtaib puttingpatientsaheadbyleavingnothingbehindanemergingtreatmentparadigminminimallyinvasivesurgicaltherapyforbenignprostatichyperplasia AT millerle puttingpatientsaheadbyleavingnothingbehindanemergingtreatmentparadigminminimallyinvasivesurgicaltherapyforbenignprostatichyperplasia AT bhattacharyyask puttingpatientsaheadbyleavingnothingbehindanemergingtreatmentparadigminminimallyinvasivesurgicaltherapyforbenignprostatichyperplasia AT dornbierra puttingpatientsaheadbyleavingnothingbehindanemergingtreatmentparadigminminimallyinvasivesurgicaltherapyforbenignprostatichyperplasia AT eltermands puttingpatientsaheadbyleavingnothingbehindanemergingtreatmentparadigminminimallyinvasivesurgicaltherapyforbenignprostatichyperplasia
_version_	1718397007489400832

Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia

Ejemplares similares